European Radiology Experimental

Table 1 Tumor volume and growth rate of groups in study-1

From: Tumor suppression effect of ultrasound-sensitive nanoparticles with focused ultrasound in a pancreas cancer xenograft model

Values	Control	GEM only	DOX with FUS	IMP301 (2 mg/kg) with FUS	IMP301 (4 mg/kg) with FUS	IMP301 (6 mg/kg) with FUS
Volume at 0 week (mm³)	37 ± 6	37 ± 4	38 ± 2	36 ± 6	39 ± 7	39 ± 3
Volume at 5th week (mm³)	164 ± 21	131 ± 14	127 ± 19	109 ± 16	98 ± 21	88 ± 18
Volume at 6th week (mm³)	307 ± 32	245 ± 48	208 ± 25	185 ± 35	121 ± 28	105 ± 22
Growth rate (mm³/week)	45 ± 5	35 ± 7	28 ± 5	25 ± 5	14 ± 4	11 ± 4
Growth rate since 3rd week (mm³/week)	67 ± 19	58 ± 18	45 ± 10	38 ± 12	18 ± 7	15 ± 7

Numbers indicate the means ± standard deviation. DOX Doxil, FUS Focused ultrasound, GEM Gemcitabine, IMP301 Doxorubicin HCl-loaded liposome

Back to article page